Roflumilast in Dermatology: A Newer Phosphodiesterase-4 Inhibitor.

Authors: Singh, Suvesh, Paul, Debopriya, Snehal, Aditi

Source: Indian Journal of Dermatology; Jan/Feb2025, Vol. 70 Issue 1, p38-41, 4p

Subject Terms: SKIN diseases, DERMATOLOGIC agents, PSORIASIS, SKIN inflammation, PATIENT safety, DERMATOLOGY, PHOSPHODIESTERASE inhibitors, SEBORRHEIC dermatitis, DRUG approval, DRUG efficacy

Company/Entity: UNITED States. Food & Drug Administration

Drug-induced Bullous Pemphigoid Secondary to Gliptin.

Authors: Singh, Suvesh, Paul, Debopriya, Snehal, Aditi

Source: Journal of the Indian Academy of Geriatrics; Jan-Mar2024, Vol. 20 Issue 1, p50-51, 2p

Subject Terms: BULLOUS pemphigoid, DRUG side effects, IMMUNOSUPPRESSIVE agents, TERBINAFINE, LISINOPRIL, HERPES zoster vaccines